Home/Filings/4/0001127602-25-012101
4//SEC Filing

Dickinson Andrew D 4

Accession 0001127602-25-012101

CIK 0000882095other

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 3:22 PM ET

Size

4.6 KB

Accession

0001127602-25-012101

Insider Transaction Report

Form 4
Period: 2025-04-15
Dickinson Andrew D
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-04-15$106.40/sh2,500$266,000168,174 total
Footnotes (1)
  • [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001310204

Filing Metadata

Form type
4
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 3:22 PM ET
Size
4.6 KB